Search - tctmd.com

Displaying 21 - 40 of 67

Sort: Relevancy | Date

Presentation TVT 2021

Two Is More Than Three: Challenging Bicuspid Anatomy

Presenter: Mathew Williams

July 21, 2021

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Todd Neale

July 20, 2021

Presentation TVT 2021

Clinical Trial Considerations for Bicuspid Aortic Valve for Disease: What Should the Next Study Look Like?

Presenter: David Cohen

July 20, 2021

Presentation TVT 2021

My "Best Practice’" Routine Bicuspid TAVR

Presenter: John Forrest

July 20, 2021

Presentation TVT 2021

Bicuspid Anatomy for TAVR: What Is Important?

Presenter: João Cavalcante

July 20, 2021

Presentation TVT 2021

The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Presenter: Mathew Williams

July 20, 2021

Presentation TVT 2021

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Presenter: John Forrest

July 20, 2021

News Conference News TVT 2020

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Shelley Wood

June 24, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

Presentation TVT 2019

Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

Presenter: Vinod Thourani

June 13, 2019

Presentation TVT 2019

Better for Bicuspids and Dry Leaflet Technology

Presenter: Horst Sievert

June 13, 2019

Presentation TVT 2019

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Calcified Bicuspid Disease) – A Case-Based Discussion

Presenter: Christopher Meduri

June 13, 2019

Presentation TVT 2019

Case: JenaValve for Pure Aortic Regurgitation

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

Latest Clinical Data in Bicuspid Disease

Presenter: John Forrest

June 13, 2019

Presentation TVT 2019

Treating AR With Current Transcatheter Valve Platforms

Presenter: David Muller

June 13, 2019

Presentation TVT 2019

Case: J-Valve for Pure Aortic Regurgitation

Presenter: Jian Ye

June 13, 2019

Presentation TVT 2019

The Next TAVR vs. SAVR Randomized Trial Should Be in Patients With Bicuspid Aortic Valves

Presenter: Raj Makkar

June 13, 2019

Presentation TVT 2019

CT Assessment for Bicuspid Valve TAVR. Annular or Supra-Annular Sizing? Coronary Access? TAVR Repeatability?

Presenter: Philipp Blanke

June 13, 2019

Presentation TVT 2019

Treating Bicuspid Valves With Current Transcatheter Valve Platforms

Presenter: Didier Tchetche

June 13, 2019

Advertisement

Two Is More Than Three: Challenging Bicuspid Anatomy

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Clinical Trial Considerations for Bicuspid Aortic Valve for Disease: What Should the Next Study Look Like?

My "Best Practice’" Routine Bicuspid TAVR

Bicuspid Anatomy for TAVR: What Is Important?

The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

Better for Bicuspids and Dry Leaflet Technology

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Calcified Bicuspid Disease) – A Case-Based Discussion

Case: JenaValve for Pure Aortic Regurgitation

Latest Clinical Data in Bicuspid Disease

Treating AR With Current Transcatheter Valve Platforms

Case: J-Valve for Pure Aortic Regurgitation

The Next TAVR vs. SAVR Randomized Trial Should Be in Patients With Bicuspid Aortic Valves

CT Assessment for Bicuspid Valve TAVR. Annular or Supra-Annular Sizing? Coronary Access? TAVR Repeatability?

Treating Bicuspid Valves With Current Transcatheter Valve Platforms

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content